The company operates manufacturing facilities in the United States, Singapore, Costa Rica, and Ireland, producing TAVR, TMTT, and Surgical products. It utilizes a variety of raw and organic materials, including resins, chemicals, electronics, metals, and animal-derived natural tissues. Some materials and components are procured from external suppliers, with certain supplies sourced from single suppliers due to sole source availability or regulatory requirements. The company collaborates closely with suppliers to manage risks and maintain supply continuity, considering alternative suppliers for critical materials but generally not pursuing immediate regulatory qualification because of established supplier relationships. Bovine tissue used in pericardial tissue valve products is sourced exclusively from the United States and Australia, regions with stringent control measures and surveillance programs, and from tissue types recognized by global health and regulatory authorities as having no risk of infectivity. Manufacturing and sterilization processes are designed to ensure biological safety against infectious agents and viruses.
Edwards Lifesciences's Comment on Supply Chain
The company operates manufacturing facilities in the United States, Singapore, Costa Rica, and Ireland, producing TAVR, TMTT, and Surgical products. It utilizes a variety of raw and organic materials, including resins, chemicals, electronics, metals, and animal-derived natural tissues. Some materials and components are procured from external suppliers, with certain supplies sourced from single suppliers due to sole source availability or regulatory requirements. The company collaborates closely with suppliers to manage risks and maintain supply continuity, considering alternative suppliers for critical materials but generally not pursuing immediate regulatory qualification because of established supplier relationships. Bovine tissue used in pericardial tissue valve products is sourced exclusively from the United States and Australia, regions with stringent control measures and surveillance programs, and from tissue types recognized by global health and regulatory authorities as having no risk of infectivity. Manufacturing and sterilization processes are designed to ensure biological safety against infectious agents and viruses.
Sources:
Edwards Lifesciences Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Edwards Lifesciences Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
